riluzole has been researched along with Age-Related Macular Degeneration in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, C | 1 |
| Ma, W | 1 |
| Zheng, W | 1 |
| Huang, H | 1 |
| Xia, R | 1 |
| Li, C | 1 |
| Zhu, X | 1 |
1 other study available for riluzole and Age-Related Macular Degeneration
| Article | Year |
|---|---|
The antioxidant effects of riluzole on the APRE-19 celll model injury-induced by t-BHP.
Topics: Antioxidants; Apoptosis; Cell Survival; Cytochromes c; Epithelial Cells; Excitatory Amino Acid Antag | 2017 |